Cybin Inc (CLXPF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CLXPF | AMGN | VRTX | REGN | BMY |
| Company | Cybin Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 3.0500 | 314.82 | 430.93 | 988.00 | 45.00 |
| High | 3.2000 | 321.44 | 439.26 | 988.96 | 45.17 |
| Low | 2.8736 | 312.87 | 428.62 | 966.34 | 44.48 |
| Last | 3.0200 | 319.94 | 436.87 | 977.89 | 44.53 |
| Change | -0.0400 | +8.53 | +8.28 | -6.75 | -0.18 |
| % Change | -1.31% | +2.74% | +1.93% | -0.69% | -0.40% |
| Volume | 864,300 | 2,076,277 | 604,965 | 378,329 | 6,271,270 |
| 20-Day Average Volume | 1,094,590 | 2,891,382 | 1,082,829 | 452,720 | 14,043,838 |
| Previous Close | 3.0600 | 311.41 | 428.59 | 984.64 | 44.71 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.8482 | 288.87 | 407.51 | 931.30 | 45.49 |
| 20-Day Raw Stochastic | 71.64% | 96.67% | 96.00% | 90.67% | 19.70% |
| 20-Day Relative Strength | 62.45% | 69.36% | 68.91% | 61.37% | 35.79% |
| Weighted Alpha | +130.72 | +43.79 | +29.93 | +30.13 | -33.17 |
| Today's Opinion | N/A | 72% Buy | 56% Buy | 72% Buy | 100% Sell |
| Previous Opinion | N/A | 56% Buy | 56% Buy | 72% Buy | 100% Sell |
| Last Month's Opinion | N/A | 40% Sell | 24% Buy | 24% Buy | 56% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +11.46% since 07/28/21 | +4.30% since 05/08/24 | +4.42% since 05/08/24 | +2.36% since 05/08/24 | +2.04% since 05/08/24 |
| Low | 2.7300 on 07/29/21 | 306.32 on 05/09/24 | 416.03 on 05/09/24 | 956.76 on 05/09/24 | 43.49 on 05/09/24 |
| High | 3.3800 on 08/02/21 | 321.44 on 05/15/24 | 439.26 on 05/15/24 | 988.96 on 05/15/24 | 45.72 on 05/14/24 |
| 1-Month | |||||
| %Chg | +42.45% since 07/02/21 | +20.72% since 04/15/24 | +10.06% since 04/15/24 | +8.88% since 04/15/24 | -8.14% since 04/15/24 |
| Low | 2.1105 on 07/08/21 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 3.3800 on 08/02/21 | 322.60 on 05/03/24 | 439.26 on 05/15/24 | 988.96 on 05/15/24 | 49.56 on 04/22/24 |
| 3-Month | |||||
| %Chg | +79.76% since 05/04/21 | +10.88% since 02/15/24 | +2.59% since 02/15/24 | +2.47% since 02/15/24 | -9.87% since 02/15/24 |
| Low | 1.3429 on 06/01/21 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 3.3800 on 08/02/21 | 322.60 on 05/03/24 | 439.26 on 05/15/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | +76.61% since 02/04/21 | +17.40% since 11/15/23 | +25.19% since 11/15/23 | +23.47% since 11/15/23 | -13.59% since 11/15/23 |
| Low | 0.9500 on 03/30/21 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 785.83 on 11/16/23 | 43.33 on 05/02/24 |
| High | 3.3800 on 08/02/21 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 453,224 | 167,051,216 | 110,598,944 | 108,493,528 | 90,631,640 |
| Shares Outstanding, K | 148,598 | 536,435 | 258,053 | 110,186 | 2,027,100 |
| Annual Sales | 650,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -24,420,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | N/A | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 11,865,000,000 |
| Last Quarter Net Income | N/A | -113,000,000 | 1,099,600,000 | 722,000,000 | -11,911,000,000 |
| 60-Month Beta | N/A | 0.60 | 0.39 | 0.17 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | N/A | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.56 | 28.55 | 26.33 | 42.91 |